Trial
NCT06833190
REGN5381 in Adult Participants With Uncontrolled Hypertension
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Regeneron Pharmaceuticals
Collaborators
—
Condition
Uncontrolled Hypertension
Intervention
REGN5381
Why stopped
Sponsor decision
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-10-23